The role of recombinant human erythropoietin in the management of anemia associated with acquired immunodeficiency syndrome.
Garnick
M B
MB
Genetics Institute, Inc., Cambridge, Boston, Mass.
Abels
R
R
Rudnick
S A
SA
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000740:Anemia / Q000188:drug therapy*; D001803:Blood Transfusion; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use
D011994:Recombinant Proteins; D004921:Erythropoietin